A new enhancer for anti-PD-1/PD-L1 immunotherapy: PCSK9 inhibition
Shengbo Sun, Zhengyang Yang, Hongwei Yao, Zhongtao Zhang
Topics & Concepts
EnhancerImmunotherapyPD-L1PCSK9Cancer researchMedicineChemistryPharmacologyImmune systemInternal medicineImmunologyCholesterolBiochemistryGeneGene expressionLipoproteinLDL receptorColorectal Cancer Treatments and StudiesCancer Immunotherapy and BiomarkersMelanoma and MAPK Pathways